Related Posts
HSCA Comments on FDA Draft Guidance for Drug Supply Chain Security Act (DSCSA) Standards
November 9, 2022
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the...
HSCA Comments on FDA “Risk Management Plans to Mitigate the Potential for Drug Shortages” Draft Guidance
August 22, 2022
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the...
HSCA Response to FDA Notifying FDA of a Discontinuance or Interruption in Manufacturing of Finished Products or Active Pharmaceutical Ingredients Draft Guidance
June 5, 2023
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the...
HSCA Comments to EPA on Proposal to Reduce Ethylene Oxide Emissions (EtO) from Commercial Sterilization Facilities and Proposed Interim Decision and Draft Risk Assessment Addendum for Ethylene Oxide
June 28, 2023
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA Comments to EPA on Proposal to Reduce Ethylene Oxide Emissions (EtO) from Commercial Sterilization Facilities and Proposed Interim Decision and Draft Risk Assessment Addendum for Ethylene Oxide
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Environmental Protection Agency (EPA) on ethylene oxide (EtO).
Please find comments regarding the proposed amendments to the National Emission Standards for Hazardous Air Pollutants (NESHAP) for the Commercial Sterilization Facilities source category here.
Please find comments regarding the proposed interim registration review decision and draft risk assessment addendum for ethylene oxide (EtO) here.